Joint marketing between BMS and Green Cross for ‘Baraclude’

Published: 2015-09-15 14:23:07

Updated: 2015-09-15 14:23:07

BMS Korea(President Hye-sun Park) will jointly sell ‘Baraclude,’ a chronic hepatitis B treatment, with Green Cross(President Eun-cheol Huh) in the domestic market. On the 11^th, the two companies announced establishment of a co-marketing contract(strategic partnership) for ‘Baraclude’ on the 1^st of September.

‘Baraclude(generic name: entecavir)’ is a chronic hepatitis B virus treatment for adul...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.